
extrakTALKS with Dr. Jon
If you’re a farmer (hemp), grower (marijuana), processor, chemist, investor, entrepreneurs – or maybe you’re just curious – this podcast is for you. Listen in as Dr. Jon talks about everything Supercritical CO2 Botanical Extraction. He will answer your questions about extraction, processing, methodology, and other how-to's when building a successful CBD business. Get your questions answered. extraktLAB is a leading-edge, CBD hemp and cannabis processing equipment manufacturer. extraktLAB also provides engineering, consulting, and design services for your business. Our supercritical CO2 extraction equipment is known for having the highest throughput, smallest footprint, lowest energy consumption, and the most scalable CO2 extraction process in the industry. Dr. Jon is the President & CEO of extraktLAB. He is a separations scientist, entrepreneur, and inventor. Dr. Jon has earned a strong track record of winning and implementing medical cannabis licenses in well-regulated, medically-modeled states.
extrakTALKS with Dr. Jon
"Full Spectrum" Extracts Key Requirements for GMP Extracts - #77
•
Dr. Jon
•
Season 3
•
Episode 77
Explore the critical requirements for GMP-compliant cannabis extracts and how they differ from traditional full-spectrum products. This guide covers:
- Four key GMP requirements for pharmaceutical ingredients
- Scientific definitions vs industry terminology
- Stability and consistency challenges
- Impurity profile management
- Therapeutic effect validation
- Processing considerations for GMP compliance
- Formulation strategies for pharmaceutical products
Essential viewing for cannabis processors targeting pharmaceutical markets and GMP certification.
Timestamps:
[00:01:05] GMP Requirements Overview
[00:01:21] Stability Requirements
[00:01:39] Consistency Standards
[00:01:50] Impurity Profile Management
[00:02:16] Therapeutic Effect Validation
[00:03:14] Scientific Definitions
[00:05:52] Impurity Profile Analysis
[00:06:38] Pharmaceutical Standards
[00:07:47] Entourage Effect Considerations
[00:09:27] Formulation Guidelines